arrow
J

Jonathan S. Wall

university of tennessee graduate school of medicine
H指数:37
被引数:4,637

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A Phase 3 Open Label Multicenter Study of I124 Evuzamitide as an Imaging Agent for the Diagnosis of Cardiac Amyloidosis Using Positron Emission Tomography Computed Tomography PETCT

I124埃夫扎米替定作为正电子发射断层扫描计算机断层扫描(PETCT)诊断心脏淀粉样变性的开放标签多中心III期研究

2026-09-090
PRE
Performance of 99mTc-p5+14 (AT-05) for the Detection of Cardiac Amyloid in Patients with Biopsy-Proven ATTR Amyloidosis and an Equivocal 99mTc-PYP Image at Diagnosis

<sup>99m</sup>Tc-p5+14 (AT-05)在活检确诊的ATTR淀粉样变性患者中,对心脏淀粉样变的检测性能及诊断时<sup>99m</sup>Tc-PYP图像不确定性的研究

2026-09-090
PRE
Design and Rationale of the REVEAL PET Study: A Study of 124I-evuzamitide to Diagnose Cardiac Amyloidosis

REVEAL PET研究的方案设计与依据:一项关于使用124I-evuzamitide诊断心肌淀粉样变性的研究

2026-06-150
PRE
A Tale of Two Tracers - A Qualitative Comparison of the PET and SPECT Amyloid-Imaging Agents, 124I-Evuzamitide (AT-01) and 99mTc-p5+14 (AT-05), that are Derived from the Same Synthetic Amyloid-Binding Peptide, p5+14

《两种示踪剂的比较——基于同一合成淀粉样蛋白结合肽p5+14的PET和SPECT淀粉样蛋白成像剂124I-Evuzamitide(AT-01)和99mTc-p5+14(AT-05)的定性比较》

2025-08-280
PRE
Characterization of AT02 Bioactivity and an Assessment of Its Potential Use As an Amyloid-Clearing Therapeutic for AL Amyloidosis

AT02生物活性的表征及其作为AL淀粉样变性淀粉样蛋白清除疗法的潜在应用评估

BLOOD
IF23.1
2024-11-051
PRE
Preliminary Observations Using 99m-Tc-Peptide p5+14 for the Detection of AL Amyloidosis Using SPECT/CT and Planar Gamma Scintigraphic Imaging

初步观察:使用99m-Tc-肽p5+14检测AL淀粉样变性,采用SPECT/CT和平面伽马闪烁成像

BLOOD
IF23.1
2024-11-050
PRE